Showing 3,101 - 3,120 results of 5,570 for search '"Oncology"', query time: 0.10s Refine Results
  1. 3101
  2. 3102
  3. 3103

    Atezolizumab neutralizing assay development: a novel way of evaluating assay cutpoint after sample pretreatment by Rachel Melendez, Jane Ruppel, Cecilia Leddy, Jenny Yang, Ann Brady, Yenny Webb-Vargas, Jochen Brumm, Lynn Kamen, Yuan Song

    Published 2025-02-01
    “…Abstract Atezolizumab, a biotherapeutic monoclonal antibody directed against PD-L1, has been shown to be efficacious in multiple oncology indications. In clinical trials, a subset of patients developed anti-atezolizumab antibodies, necessitating the development of a neutralizing antibody (NAb) assay. …”
    Get full text
    Article
  4. 3104
  5. 3105
  6. 3106
  7. 3107
  8. 3108
  9. 3109

    A pivotal decade for bispecific antibodies? by Marlena Surowka, Christian Klein

    Published 2024-12-01
    “…In the 2020s, the approval of additional bsAbs can be expected in hematological malignancies, solid tumors and non-oncology indications, establishing bsAbs as essential part of the therapeutic armamentarium.…”
    Get full text
    Article
  10. 3110
  11. 3111

    Impact of the COVID-19 Pandemic on Radiotherapy Supply by Francesco Tramacere, Artor Niccoli Asabella, Maurizio Portaluri, Corinna Altini, Cristina Ferrari, Lilia Bardoscia, Angela Sardaro

    Published 2021-01-01
    “…The COVID-19 pandemic affected the regular RT delivery to oncologic patients, owing to the delay or cancellation of procedures with the likely effect to observe worsening of local disease control and reduced survival rates in the future.…”
    Get full text
    Article
  12. 3112
  13. 3113
  14. 3114
  15. 3115
  16. 3116

    Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy by Susan Scott, Mark Sausen, Valsamo Anagnostou, Jennifer Jackson, Vincent Lam, Joseph C Murray, Lavanya Sivapalan, Jenna Vanliere Canzoniero, Blair Landon, Benjamin P. Levy

    Published 2023-01-01
    “…The clinical translation of liquid biopsies is propelled by the increasing number of ctDNA-directed interventional clinical trials in the immuno-oncology space, signifying a critical step towards implementation of liquid biopsies in precision immuno-oncology.…”
    Get full text
    Article
  17. 3117
  18. 3118
  19. 3119
  20. 3120